Kovack Advisors, Inc. Biogen Inc. Transaction History

Kovack Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 01, 2018	SELL	$257.52 - $306.91 $201,123 - $239,696	-781 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $40,840 - $57,761	-157 Reduced 16.74%	781 $214,000
Q4 2017 May 15, 2018	BUY	$307.64 - $344.58 $30,764 - $34,458	100 Added 11.93%	938 $272,000
Q4 2017 Feb 01, 2018	BUY	$307.64 - $344.58 $257,802 - $288,758	838 New	838 $267,000
Q2 2015 Nov 06, 2018	SELL	N/A	-594 Closed	0 $0
Q1 2015 Nov 13, 2018	SELL	N/A	-64 Reduced 9.73%	594 $251,000
Q4 2014 Nov 19, 2018	BUY	N/A	658	658 $223,000

998

130M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Kovack Advisors, Inc. with notifications on news.